eli lilly lawsuit tirzepatide update today A federal judge on Wednesday dismissed part of Lilly's against the Houston-based Empower Pharmacy — the latest development in the pharmaceutical giant's bid to curb sales of cheaper, less-regulated versions Eli Lilly sues Strive and

Research suggests that glucagon-like peptide-1 (GLP-1) agonists may ameliorate substance craving and

Discover GLP-1 for weight management at Synergy Face + Body by Travis Shaw MD in Richmond and Midlothian

Canadian researchers warn that side effects of Ozempic, Wegovy and other similar drugs may cause the heart muscles to atrophy, making it more difficult for users to exercise.

Paramount Peptides shows its clearest purity-focus evidence in Semaglutide and Retatrutide, with Ipamorelin also mostly recovering after a borderline miss

The higher P/E ratios for Indian firms, like Eris(39.50-65.62) could indicate investor expectations for growth from generic sales/their strong market positions